Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
The Scientist
Most Recent
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.
Harvard geneticists and anthropologists challenge the work of two economists who say there’s a link between genetic diversity and wealth.
As cholera first tore through the Europe in the mid-19th century, people tried anything to prevent the deadly disease. Then science stepped in.
With dogged persistence and an unwillingness to entertain defeat, Bruce Beutler discovered a receptor that powers the innate immune response to infections—and earned his share of a Nobel Prize.
Tracking the genetic diversity and evolution of rhinoviruses can lead to a better understanding of viral evolution, the common cold, and more dangerous infections.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
